Bulk Manufacturer of Controlled Substances Application: SpecGX, LLC, 70866 [2021-26907]
Download as PDF
<![CDATA[
70866
DATES:
Federal Register / Vol. 86, No. 236 / Monday, December 13, 2021 / Notices
January 6, 2022.
FOR FURTHER INFORMATION CONTACT:
Bridget Healy, Esq., Acting Chief
Counsel, Rules Committee Staff,
Administrative Office of the U.S. Courts,
Thurgood Marshall Federal Judiciary
Building, One Columbus Circle NE,
Suite 7–300, Washington, DC 20544,
Phone (202) 502–1820,
RulesCommittee_Secretary@
ao.uscourts.gov.
(Authority: 28 U.S.C. 2073.)
Dated: December 7, 2021.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
[FR Doc. 2021–26868 Filed 12–10–21; 8:45 am]
BILLING CODE 2210–55–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–927]
Importer of Controlled Substances
Application: Noramco, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Noramco, Inc., has applied to
be registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 12, 2022. Such
persons may also file a written request
for a hearing on the application on or
before January 12, 2022.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on September 22, 2021,
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:50 Dec 10, 2021
Jkt 256001
Noramco Inc., 500 Swedes Landing
Road, Wilmington, Delaware 19801–
4417, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
Drug
code
Controlled substance
Marihuana ...............................
Tetrahydrocannabinols ...........
Nabilone ..................................
Phenylacetone ........................
Opium, Raw ............................
Poppy Straw Concentrate .......
Noroxymorphone ....................
Tapentadol ..............................
7360
7370
7379
8501
9600
9670
9668
9780
Schedule
I
I
II
II
II
II
II
II
The company plans to import
Phenylacetone (8501), and Poppy Straw
Concentrate (9670) to bulk manufacture
other controlled substances for
distribution to its customers. The
company plans to import an
intermediate form of Tapentadol (9780)
to bulk manufacture Tapentadol for
distribution to its customers. In
reference to drug codes 7360
(Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to import a synthetic cannabidiol
and a synthetic Tetrahydrocannabinol.
No other activity for these drug codes is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–26906 Filed 12–10–21; 8:45 am]
BILLING CODE P
Drug Enforcement Administration
[Docket No. DEA–932]
Bulk Manufacturer of Controlled
Substances Application: SpecGX, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SpecGX, LLC, has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 20, 2021,
SpecGX LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147, applied to
be registered as a bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Phenylacetone ................
Drug
code
Schedule
8501
II
The company plans to manufacture
the above-listed controlled substance in
bulk for conversion to other controlled
substances. No other activity for this
drug code is authorized for this
registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–26907 Filed 12–10–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Employee Benefits Security
Administration
Agency Information Collection
Activities; Request for Public
Comment
Employee Benefits Security
Administration (EBSA), Department of
Labor.
ACTION: Notice.
AGENCY:
DEPARTMENT OF JUSTICE
SUMMARY:
issuance of the proposed registration on
or before February 11, 2022. Such
persons may also file a written request
for a hearing on the application on or
before February 11, 2022.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The Department of Labor (the
Department), in accordance with the
Paperwork Reduction Act, provides the
general public and Federal agencies
with an opportunity to comment on
proposed and continuing collections of
information. This helps the Department
assess the impact of its information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand the
Department’s information collection
requirements and provide the requested
data in the desired format. The
Employee Benefits Security
Administration (EBSA) is soliciting
comments on the proposed extension of
SUMMARY:
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 86, Number 236 (Monday, December 13, 2021)]
[Notices]
[Page 70866]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26907]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-932]
Bulk Manufacturer of Controlled Substances Application: SpecGX,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: SpecGX, LLC, has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before February 11,
2022. Such persons may also file a written request for a hearing on the
application on or before February 11, 2022.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 20, 2021, SpecGX LLC, 3600 North 2nd
Street, Saint Louis, Missouri 63147, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Phenylacetone.......................... 8501 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substance in bulk for conversion to other controlled substances. No
other activity for this drug code is authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26907 Filed 12-10-21; 8:45 am]
BILLING CODE P
